Artelo Biosciences Inc. (ARTL)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.16
0.03 (2.65%)
At close: Jan 15, 2025, 3:58 PM
1.16
0.00%
After-hours Jan 15, 2025, 03:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 6.89M | 6.63M | 2.14M | 4.42M | 337.42K | 572.77K | 3.59K | 17.03K | 14.73K |
Short-Term Investments | 10.64M | 3.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | -1.50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 3.00K | 189.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | 8.79K | 22.13K | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | -8.79K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 789.00K | 252.00K | 195.13K | 18.62K | 36.88K | 1.50K | n/a | n/a | n/a |
Total Current Assets | 18.32M | 10.32M | 2.34M | 4.44M | 396.44K | 574.27K | 3.59K | 17.03K | 14.73K |
Property-Plant & Equipment | 60.00K | 90.00K | 246.00 | 721.00 | 563.00 | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 2.04M | 2.04M | 2.04M | 2.04M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.10M | 2.32M | 2.04M | 2.04M | 563.00 | n/a | n/a | n/a | n/a |
Total Assets | 20.42M | 12.63M | 4.38M | 6.48M | 397.00K | 574.27K | 3.59K | 17.03K | 14.73K |
Account Payables | 905.00K | 493.00K | 490.22K | 348.86K | 529.27K | 28.58K | 12.94K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 40.00K | 28.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -852.00K | -488.00K | -478.26K | 323.79K | -526.57K | -27.71K | -8.49K | 1.74K | n/a |
Total Current Liabilities | 998.00K | 526.00K | 502.18K | 1.02M | 531.97K | 29.44K | 17.39K | 1.74K | n/a |
Long-Term Debt | 23.00K | 67.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 490.22K | 348.86K | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 23.00K | 67.00K | 490.22K | 348.86K | 529.27K | 28.58K | 12.94K | n/a | n/a |
Total Liabilities | 1.02M | 593.00K | 502.18K | 1.02M | 531.97K | 29.44K | 17.39K | 1.74K | n/a |
Total Debt | 63.00K | 95.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 3.00K | 25.00K | 4.99K | 3.35K | 14.00K | 11.33K | 7.64K | 7.64K | 6.00K |
Retained Earnings | -31.02M | -16.90M | -9.47M | -4.81M | -2.64M | -295.09K | -60.20K | -30.51K | -15.27K |
Comprehensive Income | -254.00K | 18.00K | 63.76K | -9.81K | -12.28K | 657.00 | n/a | n/a | n/a |
Shareholders Equity | 19.40M | 12.04M | 3.87M | 5.46M | -134.97K | 544.84K | -13.80K | 15.29K | 14.73K |
Total Investments | 9.15M | 3.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |